               SEQUENCE LISTING

<110> Nordic Bioscience A/S
      Bristol-Myers Squibb Company
      The Trustees of the University of Pennsylvania

<120> ASSAY FOR ASSESSING HEART FAILURE

<130> P20645WO

<150> US62/857,362
<151> 2019-06-05

<160> 38

<170> BiSSAP 1.3.6

<210> 1
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6

<400> 1
Lys Pro Gly Val Ile Ser Val Met Gly Thr 
1               5                   10  

<210> 2
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 elongated version

<400> 2
Lys Pro Gly Val Ile Ser Val Met Gly Thr Ala 
1               5                   10      

<210> 3
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 truncated version

<400> 3
Lys Pro Gly Val Ile Ser Val Met Gly 
1               5                   

<210> 4
<211> 16
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 antibody CDR-L1

<400> 4
Arg Ser Ser Gln Arg Ile Val His Ser Asn Gly Ile Thr Phe Leu Glu 
1               5                   10                  15      



<210> 5
<211> 7
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 antibody CDR-L2

<400> 5
Arg Val Ser Asn Arg Phe Ser 
1               5           

<210> 6
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 antibody CDR-L3

<400> 6
Phe Gln Gly Ser His Val Pro Leu Thr 
1               5                   

<210> 7
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 antibody CDR-H1

<400> 7
Asp Phe Asn Met Asn 
1               5   

<210> 8
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 antibody CDR-H2

<400> 8
Ala Ile Asn Pro His Asn Gly Ala Thr Ser Tyr Asn Gln Lys Phe Ser 
1               5                   10                  15      
Gly 
    

<210> 9
<211> 7
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 antiboday CDR-H3

<400> 9
Trp Gly Asn Gly Lys Asn Ser 
1               5           

<210> 10
<211> 79
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 antibody light chain partial sequence

<400> 10
Arg Ser Ser Gln Arg Ile Val His Ser Asn Gly Ile Thr Phe Leu Glu 
1               5                   10                  15      
Trp Tyr Leu Gln Lys Pro Gly Gln Ser Pro Lys Leu Leu Ile Tyr Arg 
            20                  25                  30          
Val Ser Asn Arg Phe Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly 
        35                  40                  45              
Ser Gly Thr Asp Phe Thr Leu Lys Ile Ser Arg Val Glu Ala Glu Asp 
    50                  55                  60                  
Leu Gly Leu Tyr Tyr Cys Phe Gln Gly Ser His Val Pro Leu Thr 
65                  70                  75                  

<210> 11
<211> 75
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 antibody heavy chain partial sequence

<400> 11
Asp Phe Asn Met Asn Trp Val Lys Gln Ser His Gly Lys Ser Leu Glu 
1               5                   10                  15      
Trp Ile Gly Ala Ile Asn Pro His Asn Gly Ala Thr Ser Tyr Asn Gln 
            20                  25                  30          
Lys Phe Ser Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr 
        35                  40                  45              
Ala Tyr Met Glu Leu Asn Ser Leu Thr Ser Asp Asp Ser Ala Val Tyr 
    50                  55                  60                  
Tyr Cys Ala Arg Trp Gly Asn Gly Lys Asn Ser 
65                  70                  75  

<210> 12
<211> 112
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 light chain variable region

<400> 12
Asp Val Val Met Thr Gln Thr Pro Leu Ser Leu Pro Val Asn Leu Gly 
1               5                   10                  15      
Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Arg Ile Val His Ser 
            20                  25                  30          
Asn Gly Ile Thr Phe Leu Glu Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              
Pro Lys Leu Leu Ile Tyr Arg Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  
Ser Arg Val Glu Ala Glu Asp Leu Gly Leu Tyr Tyr Cys Phe Gln Gly 
                85                  90                  95      
Ser His Val Pro Leu Thr Phe Gly Ala Gly Thr Arg Leu Glu Leu Lys 
            100                 105                 110         



<210> 13
<211> 116
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 antibody heavy chain variable region

<400> 13
Glu Val Gln Leu Gln Gln Ser Gly Pro Val Met Val Lys Pro Gly Thr 
1               5                   10                  15      
Ser Val Lys Thr Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Phe 
            20                  25                  30          
Asn Met Asn Trp Val Lys Gln Ser His Gly Lys Ser Leu Glu Trp Ile 
        35                  40                  45              
Gly Ala Ile Asn Pro His Asn Gly Ala Thr Ser Tyr Asn Gln Lys Phe 
    50                  55                  60                  
Ser Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  
Met Glu Leu Asn Ser Leu Thr Ser Asp Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      
Ala Arg Trp Gly Asn Gly Lys Asn Ser Trp Gly Gln Gly Thr Thr Leu 
            100                 105                 110         
Thr Val Ser Ser 
        115     

<210> 14
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3

<400> 14
Cys Pro Thr Gly Pro Gln Asn Tyr Ser Pro 
1               5                   10  

<210> 15
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 elongated version

<400> 15
Cys Pro Thr Gly Pro Gln Asn Tyr Ser Pro Gln 
1               5                   10      

<210> 16
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 truncated version

<400> 16
Cys Pro Thr Gly Pro Gln Asn Tyr Ser 
1               5                   

<210> 17
<211> 16
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 antiboday CDR-L1

<400> 17
Arg Ser Ser Gln Asn Ile Val Tyr Ser Asn Gly Asp Thr Tyr Phe Glu 
1               5                   10                  15      



<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 antibody CDR-L2

<400> 18
Lys Val Ser Gln Arg Phe Ser 
1               5           

<210> 19
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 antibody CDR-L3

<400> 19
Phe Gln Gly Ala His Asp Pro Pro Ala 
1               5                   

<210> 20
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 antibody CDR-H1

<400> 20
Gly Tyr Thr Phe Ile Asn Tyr Val Ile His 
1               5                   10  

<210> 21
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 antibody CDR-H2

<400> 21
Tyr Met Asn Pro Tyr Asn Asp Val Pro Lys Asn Asn Ala Lys Phe Arg 
1               5                   10                  15      
Gly 
    

<210> 22
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 antibody CDR-H3

<400> 22
Gly Gly Phe Phe Gly Pro Leu Ser Tyr 
1               5                   

<210> 23
<211> 79
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 antibody light chain partial sequence

<400> 23
Arg Ser Ser Gln Asn Ile Val Tyr Ser Asn Gly Asp Thr Tyr Phe Glu 
1               5                   10                  15      
Trp Tyr Leu Gln Lys Pro Gly Gln Ser Pro Lys Leu Leu Ile Tyr Lys 
            20                  25                  30          
Val Ser Gln Arg Phe Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly 
        35                  40                  45              
Ser Gly Thr Asp Phe Thr Leu Lys Ile Ser Arg Val Glu Thr Glu Asp 
    50                  55                  60                  
Leu Gly Val Tyr Tyr Cys Phe Gln Gly Ala His Asp Pro Pro Ala 
65                  70                  75                  

<210> 24
<211> 82
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 antibody heavy chain partial sequence

<400> 24
Gly Tyr Thr Phe Ile Asn Tyr Val Ile His Trp Leu Lys Gln Lys Ala 
1               5                   10                  15      
Gly Gln Gly Pro Glu Trp Ile Gly Tyr Met Asn Pro Tyr Asn Asp Val 
            20                  25                  30          
Pro Lys Asn Asn Ala Lys Phe Arg Gly Lys Ala Arg Leu Thr Ser Asp 
        35                  40                  45              
Arg Ser Ser Thr Thr Ala Tyr Met Glu Leu Asn Ser Leu Thr Ser Glu 
    50                  55                  60                  
Asp Ser Ala Val Tyr Tyr Cys Ala Arg Gly Gly Phe Phe Gly Pro Leu 
65                  70                  75                  80  
Ser Tyr 
        

<210> 25
<211> 112
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 antibody light chain variable region

<400> 25
Asp Val Leu Met Thr Gln Thr Pro Leu Ser Leu Ser Val Ser Leu Gly 
1               5                   10                  15      
Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Asn Ile Val Tyr Ser 
            20                  25                  30          
Asn Gly Asp Thr Tyr Phe Glu Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              
Pro Lys Leu Leu Ile Tyr Lys Val Ser Gln Arg Phe Ser Gly Val Pro 
    50                  55                  60                  
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  
Ser Arg Val Glu Thr Glu Asp Leu Gly Val Tyr Tyr Cys Phe Gln Gly 
                85                  90                  95      
Ala His Asp Pro Pro Ala Phe Gly Gly Gly Thr Lys Leu Glu Leu Lys 
            100                 105                 110         



<210> 26
<211> 118
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 antibody heavy chain variable region

<400> 26
Glu Val Gln Leu Gln Gln Ser Gly Pro Glu Val Leu Lys Pro Gly Ala 
1               5                   10                  15      
Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ile Asn Tyr 
            20                  25                  30          
Val Ile His Trp Leu Lys Gln Lys Ala Gly Gln Gly Pro Glu Trp Ile 
        35                  40                  45              
Gly Tyr Met Asn Pro Tyr Asn Asp Val Pro Lys Asn Asn Ala Lys Phe 
    50                  55                  60                  
Arg Gly Lys Ala Arg Leu Thr Ser Asp Arg Ser Ser Thr Thr Ala Tyr 
65                  70                  75                  80  
Met Glu Leu Asn Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      
Ala Arg Gly Gly Phe Phe Gly Pro Leu Ser Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         
Leu Val Thr Val Ser Ala 
        115             

<210> 27
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> C4M

<400> 27
Ile Leu Gly His Val Pro Gly Met Leu Leu 
1               5                   10  

<210> 28
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> C4M elongated version

<400> 28
Glu Ile Leu Gly His Val Pro Gly Met Leu Leu 
1               5                   10      

<210> 29
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> C4M truncated version

<400> 29
Leu Gly His Val Pro Gly Met Leu Leu 
1               5                   

<210> 30
<211> 440
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 antibody heavy chain

<400> 30
Glu Val Gln Leu Gln Gln Ser Gly Pro Val Met Val Lys Pro Gly Thr 
1               5                   10                  15      
Ser Val Lys Thr Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Phe 
            20                  25                  30          
Asn Met Asn Trp Val Lys Gln Ser His Gly Lys Ser Leu Glu Trp Ile 
        35                  40                  45              
Gly Ala Ile Asn Pro His Asn Gly Ala Thr Ser Tyr Asn Gln Lys Phe 
    50                  55                  60                  
Ser Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  
Met Glu Leu Asn Ser Leu Thr Ser Asp Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      
Ala Arg Trp Gly Asn Gly Lys Asn Ser Trp Gly Gln Gly Thr Thr Leu 
            100                 105                 110         
Thr Val Ser Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro Leu Ala 
        115                 120                 125             
Pro Gly Ser Ala Ala Gln Thr Asn Ser Met Val Thr Leu Gly Cys Leu 
    130                 135                 140                 
Val Lys Gly Tyr Phe Pro Glu Pro Val Thr Val Thr Trp Asn Ser Gly 
145                 150                 155                 160 
Ser Leu Ser Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Asp 
                165                 170                 175     
Leu Tyr Thr Leu Ser Ser Ser Val Thr Val Pro Ser Ser Thr Trp Pro 
            180                 185                 190         
Ser Glu Thr Val Thr Cys Asn Val Ala His Pro Ala Ser Ser Thr Lys 
        195                 200                 205             
Val Asp Lys Lys Ile Val Pro Arg Asp Cys Gly Cys Lys Pro Cys Ile 
    210                 215                 220                 
Cys Thr Val Pro Glu Val Ser Ser Val Phe Ile Phe Pro Pro Lys Pro 
225                 230                 235                 240 
Lys Asp Val Leu Thr Ile Thr Leu Thr Pro Lys Val Thr Cys Val Val 
                245                 250                 255     
Val Asp Ile Ser Lys Asp Asp Pro Glu Val Gln Phe Ser Trp Phe Val 
            260                 265                 270         
Asp Asp Val Glu Val His Thr Ala Gln Thr Gln Pro Arg Glu Glu Gln 
        275                 280                 285             
Phe Asn Ser Thr Phe Arg Ser Val Ser Glu Leu Pro Ile Met His Gln 
    290                 295                 300                 
Asp Trp Leu Asn Gly Lys Glu Phe Lys Cys Arg Val Asn Ser Ala Ala 
305                 310                 315                 320 
Phe Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Thr Lys Gly Arg Pro 
                325                 330                 335     
Lys Ala Pro Gln Val Tyr Thr Ile Pro Pro Pro Lys Glu Gln Met Ala 
            340                 345                 350         
Lys Asp Lys Val Ser Leu Thr Cys Met Ile Thr Asp Phe Phe Pro Glu 
        355                 360                 365             
Asp Ile Thr Val Glu Trp Gln Trp Asn Gly Gln Pro Ala Glu Asn Tyr 
    370                 375                 380                 
Lys Asn Thr Gln Pro Ile Met Asp Thr Asp Gly Ser Tyr Phe Val Tyr 
385                 390                 395                 400 
Ser Lys Leu Asn Val Gln Lys Ser Asn Trp Glu Ala Gly Asn Thr Phe 
                405                 410                 415     
Thr Cys Ser Val Leu His Glu Gly Leu His Asn His His Thr Glu Lys 
            420                 425                 430         
Ser Leu Ser His Ser Pro Gly Lys 
        435                 440 

<210> 31
<211> 219
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C6 light chain

<400> 31
Asp Val Val Met Thr Gln Thr Pro Leu Ser Leu Pro Val Asn Leu Gly 
1               5                   10                  15      
Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Arg Ile Val His Ser 
            20                  25                  30          
Asn Gly Ile Thr Phe Leu Glu Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              
Pro Lys Leu Leu Ile Tyr Arg Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  
Ser Arg Val Glu Ala Glu Asp Leu Gly Leu Tyr Tyr Cys Phe Gln Gly 
                85                  90                  95      
Ser His Val Pro Leu Thr Phe Gly Ala Gly Thr Arg Leu Glu Leu Lys 
            100                 105                 110         
Arg Ala Asp Ala Ala Pro Thr Val Ser Ile Phe Pro Pro Ser Ser Glu 
        115                 120                 125             
Gln Leu Thr Ser Gly Gly Ala Ser Val Val Cys Phe Leu Asn Asn Phe 
    130                 135                 140                 
Tyr Pro Lys Asp Ile Asn Val Lys Trp Lys Ile Asp Gly Ser Glu Arg 
145                 150                 155                 160 
Gln Asn Gly Val Leu Asn Ser Trp Thr Asp Gln Asp Ser Lys Asp Ser 
                165                 170                 175     
Thr Tyr Ser Met Ser Ser Thr Leu Thr Leu Thr Lys Asp Glu Tyr Glu 
            180                 185                 190         
Arg His Asn Ser Tyr Thr Cys Glu Ala Thr His Lys Thr Ser Thr Ser 
        195                 200                 205             
Pro Ile Val Lys Ser Phe Asn Arg Asn Glu Cys 
    210                 215                 

<210> 32
<211> 13
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Linked to OVA

<220> 
<223> PRO-C3 immunogenic peptide

<400> 32
Cys Gly Gly Cys Pro Thr Gly Pro Gln Asn Tyr Ser Pro 
1               5                   10              

<210> 33
<211> 13
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Linked to Biotin

<220> 
<223> PRO-C3 screening peptide

<400> 33
Cys Gly Gly Cys Pro Thr Gly Pro Gln Asn Tyr Ser Pro 
1               5                   10              

<210> 34
<211> 224
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 antibody heavy chain

<400> 34
Glu Val Gln Leu Gln Gln Ser Gly Pro Glu Val Leu Lys Pro Gly Ala 
1               5                   10                  15      
Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ile Asn Tyr 
            20                  25                  30          
Val Ile His Trp Leu Lys Gln Lys Ala Gly Gln Gly Pro Glu Trp Ile 
        35                  40                  45              
Gly Tyr Met Asn Pro Tyr Asn Asp Val Pro Lys Asn Asn Ala Lys Phe 
    50                  55                  60                  
Arg Gly Lys Ala Arg Leu Thr Ser Asp Arg Ser Ser Thr Thr Ala Tyr 
65                  70                  75                  80  
Met Glu Leu Asn Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      
Ala Arg Gly Gly Phe Phe Gly Pro Leu Ser Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         
Leu Val Thr Val Ser Ala Ala Lys Thr Thr Ala Pro Ser Val Tyr Pro 
        115                 120                 125             
Leu Ala Pro Val Cys Gly Asp Thr Thr Gly Ser Ser Val Thr Leu Gly 
    130                 135                 140                 
Cys Leu Val Lys Gly Tyr Phe Pro Glu Pro Val Thr Leu Thr Trp Asn 
145                 150                 155                 160 
Ser Gly Ser Leu Ser Ser Gly Val His Thr Phe Pro Ala Val Leu Gln 
                165                 170                 175     
Ser Asp Leu Tyr Thr Leu Ser Ser Ser Val Thr Val Thr Ser Ser Thr 
            180                 185                 190         
Trp Pro Ser Gln Ser Ile Thr Cys Asn Val Ala His Pro Ala Ser Ser 
        195                 200                 205             
Thr Lys Val Asp Lys Lys Ile Glu Pro Arg Gly Pro Thr Ile Lys Pro 
    210                 215                 220                 



<210> 35
<211> 219
<212> PRT
<213> Artificial Sequence


<220> 
<223> PRO-C3 antibody light chain

<400> 35
Asp Val Leu Met Thr Gln Thr Pro Leu Ser Leu Ser Val Ser Leu Gly 
1               5                   10                  15      
Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Asn Ile Val Tyr Ser 
            20                  25                  30          
Asn Gly Asp Thr Tyr Phe Glu Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              
Pro Lys Leu Leu Ile Tyr Lys Val Ser Gln Arg Phe Ser Gly Val Pro 
    50                  55                  60                  
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  
Ser Arg Val Glu Thr Glu Asp Leu Gly Val Tyr Tyr Cys Phe Gln Gly 
                85                  90                  95      
Ala His Asp Pro Pro Ala Phe Gly Gly Gly Thr Lys Leu Glu Leu Lys 
            100                 105                 110         
Arg Ala Asp Ala Ala Pro Thr Val Ser Ile Phe Pro Pro Ser Ser Glu 
        115                 120                 125             
Gln Leu Thr Ser Gly Gly Ala Ser Val Val Cys Phe Leu Asn Asn Phe 
    130                 135                 140                 
Tyr Pro Lys Asp Ile Asn Val Lys Trp Lys Ile Asp Gly Ser Glu Arg 
145                 150                 155                 160 
Gln Asn Gly Val Leu Asn Ser Trp Thr Asp Gln Asp Ser Lys Asp Ser 
                165                 170                 175     
Thr Tyr Ser Met Ser Ser Thr Leu Thr Leu Thr Lys Asp Glu Tyr Glu 
            180                 185                 190         
Arg His Asn Ser Tyr Thr Cys Glu Ala Thr His Lys Thr Ser Thr Ser 
        195                 200                 205             
Pro Ile Val Lys Ser Phe Asn Arg Asn Glu Cys 
    210                 215                 

<210> 36
<211> 13
<212> PRT
<213> Artificial Sequence


<220> 
<223> C4M immunogenic peptide

<220> 
<221> SITE
<222> 13
<223> linked to KLH

<400> 36
Ile Leu Gly His Val Pro Gly Met Leu Leu Gly Gly Cys 
1               5                   10              

<210> 37
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> C4M biotinylated peptide

<220> 
<221> SITE
<222> 11
<223> linked to biotin

<400> 37
Ile Leu Gly His Val Pro Gly Met Leu Leu Lys 
1               5                   10      

<210> 38
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Linked to biotin

<220> 
<223> PRO-C6 biotinylated peptide

<400> 38
Lys Pro Gly Val Ile Ser Val Met Gly Thr 
1               5                   10  

